Lineage Cell Therapeutics In shares owned by BlackRock
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.8M | 2.2M | 1.69 |
| 2025-06-30 | $2.1M | 2.3M | 0.91 |
| 2025-03-31 | $5.2M | 12M | 0.45 |
| 2024-12-31 | $5.1M | 10M | 0.50 |
| 2024-09-30 | $9.0M | 9.9M | 0.91 |